Clinical Trial Update: Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of everolimus in selected patients with metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Melanoma, TOR Serine-Threonine Kinases | Phase 2 | Status: UNKNOWN